Wednesday, 26 August 2026European Markets

NHOA Stock Is 12% Down So Far On Wednesday

Loading stream...

(vianews) - shares of nhoa (cac 40: nhoa.pa) slid by a staggering 12.46% to €5.20 at 14:09 est on wednesday, after five sequential sessions in a row of losses. cac 40 is sliding 0.05% to €7,341.22, after five sequential sessions in a row of gains. this seems, up to now, a somewhat down trend exchanging session today.

nhoa's last close was €6.36, 57.6% below its 52-week high of €15.00.

about nhoa

nhoa s.a. provides energy storage and e-mobility solutions. the company offers solar plus storage, utility-scale storage, and industrial microgrids. it also provides charging services and devices for electric and hybrid vehicles. the company offers energy house, power house, and hybrid house; and hyess, a technology platform for the integration of energy storage system, renewable generation source, as well as conventional generators, as well as atlante, an estation that provides fast charging solution. the company was formerly known as engie eps s.a. and changed its name to nhoa s.a. in july 2021. nhoa s.a. is based in paris, france. nhoa s.a. is a subsidiary of taiwan cement corporation.

earnings per share

as for profitability, nhoa has a trailing twelve months eps of €-1.3.

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -58.11%.

more news about nhoa (nhoa.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com